TETmedical Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.53M

  • Investors
  • 13

TETmedical General Information

Description

Developer of an in vitro diagnostic nanomedicine platform designed for clinical diagnostic use. The company's platform uses tethered enzymes bound to silica nanoparticles to form a stable molecular system capable of rapid catalytic reactions, high analytical sensitivity, and compatibility with standard laboratory plate readers, enabling hospital and emergency department diagnostics to support time-sensitive disease assessment, biomarker detection across proteins, enzymes, viruses, and microRNAs, and informed clinical decision making with reduced uncertainty.

Contact Information

Website
www.tetmedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71 Riverlawn Drive
  • Fair Haven, NJ 07704
  • United States
Primary Industry
Diagnostic Equipment
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 71 Riverlawn Drive
  • Fair Haven, NJ 07704
  • United States

TETmedical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TETmedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 24-Jun-2026 $3.53M Completed Startup
6. Seed Round 15-Feb-2024 Completed Startup
5. Seed Round 13-Jun-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant Completed Pre-Clinical Trials
2. Grant 04-May-2023 $2M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2021 Completed Pre-Clinical Trials
To view TETmedical’s complete valuation and funding history, request access »

TETmedical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 1
Seed 2
To view TETmedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

TETmedical Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

TETmedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260185138-A1 Apparatus and methods using coupled enzyme luminescence assays for the detection of analytes and biomarkers Pending 29-Dec-2022
US-12306187-B2 Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers Active 29-Dec-2022
US-20240218422-A1 Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers Active 29-Dec-2022
US-20240219387-A1 Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers Pending 29-Dec-2022
US-20250244328-A1 Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers Inactive 29-Dec-2022 G01N33/573
To view TETmedical’s complete patent history, request access »

TETmedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TETmedical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bantam Group Angel Group Minority
Frontier Angels Angel Group Minority
Metis Innovative Venture Capital Minority
NuFund Venture Group Angel Group Minority
5150 Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

TETmedical FAQs

  • When was TETmedical founded?

    TETmedical was founded in 2021.

  • Where is TETmedical headquartered?

    TETmedical is headquartered in Fair Haven, NJ.

  • What is the size of TETmedical?

    TETmedical has 7 total employees.

  • What industry is TETmedical in?

    TETmedical’s primary industry is Diagnostic Equipment.

  • Is TETmedical a private or public company?

    TETmedical is a Private company.

  • What is TETmedical’s current revenue?

    The current revenue for TETmedical is .

  • How much funding has TETmedical raised over time?

    TETmedical has raised $7.49M.

  • Who are TETmedical’s investors?

    Bantam Group, Frontier Angels, Metis Innovative, NuFund Venture Group, and 5150 Capital are 5 of 13 investors who have invested in TETmedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process